18.07.25 |
Novo Nordisk Buy |
UBS AG |
|
18.07.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
16.07.25 |
Novo Nordisk Buy |
UBS AG |
|
15.07.25 |
Novo Nordisk Hold |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
|
11.07.25 |
Novo Nordisk Buy |
UBS AG |
|
09.07.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
03.07.25 |
Novo Nordisk Buy |
UBS AG |
|
01.07.25 |
Novo Nordisk Buy |
UBS AG |
|
30.06.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
30.06.25 |
Novo Nordisk Buy |
UBS AG |
|
24.06.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
24.06.25 |
Novo Nordisk Buy |
UBS AG |
|
23.06.25 |
Novo Nordisk Underperform |
Jefferies & Company Inc. |
|
23.06.25 |
Novo Nordisk Overweight |
Barclays Capital |
|
23.06.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
20.06.25 |
Novo Nordisk Buy |
UBS AG |
|
17.06.25 |
Novo Nordisk Buy |
UBS AG |
|
16.06.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
13.06.25 |
Novo Nordisk Buy |
UBS AG |
|
12.06.25 |
Novo Nordisk Market-Perform |
Bernstein Research |
|
09.06.25 |
Novo Nordisk Buy |
UBS AG |
|
06.06.25 |
Novo Nordisk Buy |
UBS AG |
|
06.06.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
02.06.25 |
Novo Nordisk Buy |
UBS AG |
|
02.06.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
27.05.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
19.05.25 |
Novo Nordisk Buy |
UBS AG |
|
19.05.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
16.05.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
16.05.25 |
Novo Nordisk Hold |
Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
|
14.05.25 |
A.P. Moeller - Maersk A-S Hold |
Deutsche Bank AG |
|
12.05.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
12.05.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|
12.05.25 |
Novo Nordisk Buy |
Goldman Sachs Group Inc. |
|
09.05.25 |
A.P. Moeller - Maersk A-S Underperform |
Bernstein Research |
|
09.05.25 |
Novo Nordisk Buy |
UBS AG |
|
08.05.25 |
Novo Nordisk Halten |
DZ BANK |
|
08.05.25 |
Novo Nordisk Buy |
Deutsche Bank AG |
|
08.05.25 |
Novo Nordisk Buy |
UBS AG |
|
07.05.25 |
Novo Nordisk Overweight |
JP Morgan Chase & Co. |
|